ConductScience.org, home

Paper33712445

Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.

Hubert P and 15 others. J Immunother Cancer, 2021. Cited by 173 papers, by iCite.

Cite this record

ConductScience Library. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Papers, record 33712445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33712445

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
173
iCite
Relative citation ratio, by iCite
9.33
iCite
Revised in PubMed
2024-10-11
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hubert PPascale
2Roncarati PPatrick
3Demoulin SStephanie
4Pilard CCharlotte
5Ancion MMarie
6Reynders CCelia
7Lerho TThomas
8Bruyere DDiane
9Lebeau AAlizee
10Radermecker CCoraline
11Meunier MMargot
12Nokin MJMarie-Julie
13Hendrick EElodie
14Peulen OOlivier
15Delvenne PPhilippe
16Herfs MMichaelhttps://orcid.org/0000-0002-4382-8997

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
Glycyrrhizic AcidMajor topic
HMGB1 ProteinMajor topic
Immune Checkpoint InhibitorsMajor topic
Lung NeoplasmsMajor topic
Peptide FragmentsMajor topic
S100 ProteinsMajor topic
Tumor MicroenvironmentMajor topic
Uterine Cervical NeoplasmsMajor topic
Animals
Female
Humans
Mice
Adaptive Immunity
Cell Line, Tumor
Macrophages
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Nude
RAW 264.7 Cells
Signal Transduction
Tumor Burden

Source PubMed

Download CSV of topics

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123243584Targeting PD-1/PD-L1 interactions for cancer immunotherapy.Oncoimmunology2012https://conductscience.org/library/papers/23243584PubMed
230345906Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.N Engl J Med2018https://conductscience.org/library/papers/30345906PubMed
323811849Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.Cell Death Differ2014https://conductscience.org/library/papers/23811849PubMed
410952726High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.J Exp Med2000https://conductscience.org/library/papers/10952726PubMed
510398600HMG-1 as a late mediator of endotoxin lethality in mice.Science1999https://conductscience.org/library/papers/10398600PubMed
620370557Reactive oxygen species in cancer.Free Radic Res2010https://conductscience.org/library/papers/20370557PubMed
728848055Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis.Cancer Immunol Res2017https://conductscience.org/library/papers/28848055PubMed
822869893Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release.J Exp Med2012https://conductscience.org/library/papers/22869893PubMed
922105604Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).Mol Med2012https://conductscience.org/library/papers/22105604PubMed
1029658856Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.N Engl J Med2018https://conductscience.org/library/papers/29658856PubMed
1127383136HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells.DNA Cell Biol2016https://conductscience.org/library/papers/27383136PubMed
121846317Production of large amounts of hydrogen peroxide by human tumor cells.Cancer Res1991https://conductscience.org/library/papers/1846317PubMed
1320547845A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20547845PubMed
1430796203Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion.Oncogenesis2019https://conductscience.org/library/papers/30796203PubMed
1529700411A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.Br J Cancer2018https://conductscience.org/library/papers/29700411PubMed
1618631454Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.Immunity2008https://conductscience.org/library/papers/18631454PubMed
1727161491The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.Nat Commun2016https://conductscience.org/library/papers/27161491PubMed
1822580958HMGB1 in development and diseases of the central nervous system.Mol Neurobiol2012https://conductscience.org/library/papers/22580958PubMed
1927138582Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.J Clin Oncol2016https://conductscience.org/library/papers/27138582PubMed
2029463549Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.Clin Cancer Res2018https://conductscience.org/library/papers/29463549PubMed

See all 61 referencesDownload CSV of references

Cited by125

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.

PMIDTitleJournalYearIn PapersSource
42980800HMGB1 expression in CT26 murine cancer cells modulates the tumor microenvironment and limits local anti-tumor immunity.Cell Mol Life Sci2026https://conductscience.org/library/papers/42980800PubMed
42840204GULP1 Fuels Resistance to PD-1 Blockade through Lipid-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages in Gastric Cancer.Cancer Commun (Lond)2026https://conductscience.org/library/papers/42840204PubMed
42812529Pan-Cancer Landscape of the Novel Oxygen Sensor ADO and Its Potential Role in Hepatocellular Carcinoma.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42812529PubMed
42794625HMGB1 Post-Translational Modifications in Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: Current Evidence, Emerging Mechanistic Concepts, and Unresolved Questions.Int J Mol Sci2026https://conductscience.org/library/papers/42794625PubMed
42737756Damage-Associated Molecular Patterns in Mesothelioma: Drivers of Inflammation and Therapeutic Targets.Int J Mol Sci2026https://conductscience.org/library/papers/42737756PubMed
42713311The double-edged sword of SASP in breast cancer: from tumor suppression to progression and therapy resistance.Front Oncol2026https://conductscience.org/library/papers/42713311PubMed
42633379DAMPs, PAMPs, and Alarmins: From Mechanism to Therapy.MedComm (2020)2026https://conductscience.org/library/papers/42633379PubMed
42591645Integrative analysis of HMGB3 in esophageal carcinoma: expression profile, prognostic significance, and immune microenvironment associations.Transl Cancer Res2026https://conductscience.org/library/papers/42591645PubMed
42433356Lipopolysaccharide and HMGB1: key regulatory factors in the pathophysiology of sepsis a mechanistic and therapeutic review.Front Immunol2026https://conductscience.org/library/papers/42433356PubMed
42343654Revealing the Biological Effect of the N-glycosylation of High-Mobility Group Box 1 (HMGB1) Facilitated by Chemical Protein Synthesis.J Am Chem Soc2026https://conductscience.org/library/papers/42343654PubMed
42111273Recent Advances in Antitumor Nanomedicine Based on Covalent Organic Frameworks.Int J Nanomedicine2026https://conductscience.org/library/papers/42111273PubMed
42067772Context-dependent release of HMGB1: cell death mode, cell type and LPS stress drive monomer and heterocomplex formation.Mol Med2026https://conductscience.org/library/papers/42067772PubMed
42023220From immune desert to hot tumor: the tripartite synergy of tumor microenvironment-exosomes-immunogenic cell death in pioneering solutions.Front Immunol2026https://conductscience.org/library/papers/42023220PubMed
41998294Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics.Apoptosis2026https://conductscience.org/library/papers/41998294PubMed
41939886FLASH radiotherapy and immunotherapy synergy: mechanisms, strategies, and clinical translation prospects.Front Immunol2026https://conductscience.org/library/papers/41939886PubMed
41931634TLR2 signaling regulates T cell exclusion in pancreatic ductal adenocarcinoma.JCI Insight2026https://conductscience.org/library/papers/41931634PubMed
41924652HMGB1 as Double-Edged Regulator of Cancer Therapy: Mechanistic Roles in Chemotherapy Resistance and Immunotherapy Response.Onco Targets Ther2026https://conductscience.org/library/papers/41924652PubMed
41822488Prognostic significance and regulatory role of ACOT7 in the tumor immune microenvironment of breast invasive ductal carcinoma: a multi-omics analysis.Front Immunol2026https://conductscience.org/library/papers/41822488PubMed
41783547Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment.Int J Nanomedicine2026https://conductscience.org/library/papers/41783547PubMed
41688736The redox-sensitive protein HMGB1: intracellular and extracellular roles.Exp Mol Med2026https://conductscience.org/library/papers/41688736PubMed

See all 125 cited byDownload CSV of cited by

Genes34

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGER177PubTator's text mininghttps://conductscience.org/library/genes/177NCBI Gene
ATP8B15205PubTator's text mininghttps://conductscience.org/library/genes/5205NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CCR71236PubTator's text mininghttps://conductscience.org/library/genes/1236NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD839308PubTator's text mininghttps://conductscience.org/library/genes/9308NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FCGR2A2212PubTator's text mininghttps://conductscience.org/library/genes/2212NCBI Gene
FLT3LG2323PubTator's text mininghttps://conductscience.org/library/genes/2323NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene

See all 34 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33712445

GET https://conductscience.org/api/papers/v1/33712445/references?page=2